Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot .
Mucaji P, Atanasov AG, Bak A, Kozik V, Sieron K, Olsen M, Pan W, Liu Y, Hu S, Lan J, Haider N, Musiol R, Vanco J, Diederich M, Ji S, Zitko J, Wang D, Agbaba D, Nikolic K, Oljacic S, Vucicevic J, Jezova D, Tsantili-Kakoulidou A, Tsopelas F, Giaginis C, Kowalska T, Sajewicz M, Silberring J, Mielczarek P, Smoluch M, Jendrzejewska I, Polanski J, Jampilek J. Mucaji P, et al. Among authors: oljacic s. Molecules. 2017 Oct 28;22(11):1848. doi: 10.3390/molecules22111848. Molecules. 2017. PMID: 29143778 Free PMC article.
Quantitative structure-activity relationships of xanthen-3-one and xanthen-1,8-dione derivatives and design of new compounds with enhanced antiproliferative activity on HeLa cervical cancer cells.
Zukić S, Oljacic S, Nikolic K, Veljović E, Špirtović-Halilović S, Osmanović A, Završnik D. Zukić S, et al. Among authors: oljacic s. J Biomol Struct Dyn. 2021 Jul;39(11):4026-4036. doi: 10.1080/07391102.2020.1775125. Epub 2020 Jun 11. J Biomol Struct Dyn. 2021. PMID: 32462973
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer.
Beljkas M, Ilic A, Cebzan A, Radovic B, Djokovic N, Ruzic D, Nikolic K, Oljacic S. Beljkas M, et al. Among authors: oljacic s. Pharmaceutics. 2023 Nov 3;15(11):2581. doi: 10.3390/pharmaceutics15112581. Pharmaceutics. 2023. PMID: 38004560 Free PMC article. Review.
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease.
Bagán A, Rodriguez-Arévalo S, Taboada-Jara T, Griñán-Ferré C, Pallàs M, Brocos-Mosquera I, Callado LF, Morales-García JA, Pérez B, Diaz C, Fernández-Godino R, Genilloud O, Beljkas M, Oljacic S, Nikolic K, Escolano C. Bagán A, et al. Among authors: oljacic s. Pharmaceutics. 2023 Sep 25;15(10):2381. doi: 10.3390/pharmaceutics15102381. Pharmaceutics. 2023. PMID: 37896141 Free PMC article.
Evaluation of novel compounds as anti-bacterial or anti-virulence agents.
Filipić B, Ušjak D, Rambaher MH, Oljacic S, Milenković MT. Filipić B, et al. Among authors: oljacic s. Front Cell Infect Microbiol. 2024 Mar 6;14:1370062. doi: 10.3389/fcimb.2024.1370062. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38510964 Free PMC article. Review.